Effectiveness of Favipiravir monotherapy in the treatment of COVID-19: real world data analysis from Thailand
{{output}}
Background: Previous studies showed that Favipiravir, a selective viral ribonucleic acid dependent-ribonucleic acid polymerase inhibitor, exhibited a trend of clinical improvement within 14 days and promoted viral clearance by da... ...
